The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
When patients present with clinically complex medical needs, and the appropriate medication is not locally available, or shortages disrupt supply, Clinigen provides access to a board range of high-quality unlicensed, and hard-to-source medicines.
A multi-lingual experts’ team, 35 years of experience
Access to 1400+ medicines, supplying 120+ countries, across Europe, North America, Africa and Asia Pacific (inc. Japan)
We work closely with the relevant authorities and use efficient international couriers to deliver medicines in a timely manner.
Managed Access
We enable early acces to promising new medicines for patients with unmet medical needs.
200+ managed access programs.
Unlicensed Medicines
We stock the most widely used unlicensed medicines, giving you fast access to niche medicines, and we have sustainable global networks to source any request for unlicensed medicines.
For more information, please visit: https://www.clinigengroup.com/